Table 5 Number of children and adult respondents taking Anti-Oxidants in the UK and Germany
From: Impact of Friedreich’s Ataxia on health-care resource utilization in the United Kingdom and Germany
Prescription drugs (UK)1 | Non-prescription (UK)1 | Prescription drugs (Germany)2 | Non-prescription (Germany)3 | |||||
|---|---|---|---|---|---|---|---|---|
Child | Adult | Child | Adult | Child | Adult | Child | Adult | |
Idebenone | 9 (12%) | 1 (1.3%) | 1 (1.3%) | 1 (1.3%) | 5 (17.9%) | 1 (3.6%) | 3* (10.7%) | 1* (3.6%) |
Co-enzyme Q-10 | 6 (8%) | 3 (4%) | 3 (4%) | 5 (6.7%) | 0 (0%) | 1 (3.6%) | 0 (0%) | 0 (0%) |